Business & Industry
- Novartis shareholders approve the proposed 100% Spin-off of Sandoz
- Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator
- GSK and Save the Children renew award-winning partnership, with focus on 'zero dose' children who have never received a vaccine
- Roche's Alecensa delivers unprecedented Phase III results for people with ALK-positive early-stage lung cancer
- BlueRock's Phase I study with bemdaneprocel in patients with Parkinson's disease meets primary endpoint
Research & Development
- Cancer drug conquers COVID inflammation
- A suit of armor for cancer-fighting cells
- Preventing the tissue's response to stiffness may be key to slowing the progression of breast tumors
- A protein on cancer cells supports the immune response against tumors
- Turmeric may be as good for treating indigestion as drug to curb excess stomach acid
- Antidepressant use in people with both physical health problems and depression
- A free online tool can help prostate cancer patients save on out-of-pocket drug costs
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants
- FDA approves first oral treatment for postpartum depression
- FDA approves first nonprescription daily oral contraceptive
- FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy
- FDA announces additional steps to modernize clinical trials